Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Evolent Health Inc

9EH
Current price
12 EUR 0 EUR (0.00%)
Last closed 12.67 USD
ISIN US30050B1017
Sector Healthcare
Industry Health Information Services
Exchange Frankfurt Exchange
Capitalization 1 536 747 264 USD
Yield for 12 month -57.98 %
1Y
3Y
5Y
10Y
15Y
9EH
21.11.2021 - 28.11.2021

Evolent Health, Inc., through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. In addition, the company provides holistic total cost of care management. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia. Address: 1812 N. Moore Street, Arlington, VA, United States, 22209

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

31.73 USD

P/E ratio

Dividend Yield

Current Year

+1 963 896 000 USD

Last Year

+1 352 013 000 USD

Current Quarter

+621 401 000 USD

Last Quarter

+647 145 000 USD

Current Year

+460 470 000 USD

Last Year

+316 584 000 USD

Current Quarter

+80 693 000 USD

Last Quarter

+76 673 000 USD

Key Figures 9EH

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 102 758 000 USD
Operating Margin TTM -1.98 %
PE Ratio
Return On Assets TTM 0.26 %
PEG Ratio -1.37
Return On Equity TTM -5.78 %
Wall Street Target Price 31.73 USD
Revenue TTM 2 464 253 952 USD
Book Value 9.03 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 21.6 %
Dividend Yield
Gross Profit TTM 316 584 000 USD
Earnings per share -0.92 USD
Diluted Eps TTM -0.92 USD
Most Recent Quarter III 2024
Quarterly Earnings Growth YOY
Profit Margin -2.93 %

Dividend Analytics 9EH

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History 9EH

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation 9EH

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 7.5245
Enterprise Value Revenue 0.8422
Price Sales TTM 0.6236
Enterprise Value EBITDA 33.6169
Price Book MRQ 1.4795

Financials 9EH

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators 9EH

For 52 weeks

13.31 USD 35 USD
50 Day MA 26.83 USD
Shares Short Prior Month 14 036 939
200 Day MA 26.89 USD
Short Ratio 6.55
Shares Short 10 899 772
Short Percent 10.67 %